227 related articles for article (PubMed ID: 10936889)
1. p27 Expression, a cyclin dependent kinase inhibitor in breast carcinoma.
Barbareschi M
Adv Clin Path; 1999 Oct; 3(4):119-27. PubMed ID: 10936889
[TBL] [Abstract][Full Text] [Related]
2. Cyclin-dependent kinase inhibitor p27Kip1 expression and interaction with other cell cycle-associated proteins in mammary carcinoma.
Gillett CE; Smith P; Peters G; Lu X; Barnes DM
J Pathol; 1999 Jan; 187(2):200-6. PubMed ID: 10365095
[TBL] [Abstract][Full Text] [Related]
3. Deregulated expression of p27(Kip1) in human breast cancers.
Sgambato A; Zhang YJ; Arber N; Hibshoosh H; Doki Y; Ciaparrone M; Santella RM; Cittadini A; Weinstein IB
Clin Cancer Res; 1997 Oct; 3(10):1879-87. PubMed ID: 9815577
[TBL] [Abstract][Full Text] [Related]
4. Expression of p27/Kip1 is down-regulated in human prostate carcinoma progression.
Fernández PL; Arce Y; Farré X; Martínez A; Nadal A; Rey MJ; Peiró N; Campo E; Cardesa A
J Pathol; 1999 Apr; 187(5):563-6. PubMed ID: 10398122
[TBL] [Abstract][Full Text] [Related]
5. Prognostic value of cell cycle proteins p27(kip1) and MIB-1, and the cell adhesion protein CD44s in surgically treated patients with prostate cancer.
Vis AN; Noordzij MA; Fitoz K; Wildhagen MF; Schröder FH; van der Kwast TH
J Urol; 2000 Dec; 164(6):2156-61. PubMed ID: 11061947
[TBL] [Abstract][Full Text] [Related]
6. The cell cycle inhibitor p27 is an independent prognostic marker in small (T1a,b) invasive breast carcinomas.
Tan P; Cady B; Wanner M; Worland P; Cukor B; Magi-Galluzzi C; Lavin P; Draetta G; Pagano M; Loda M
Cancer Res; 1997 Apr; 57(7):1259-63. PubMed ID: 9102210
[TBL] [Abstract][Full Text] [Related]
7. Multiple functions of p27(Kip1) and its alterations in tumor cells: a review.
Sgambato A; Cittadini A; Faraglia B; Weinstein IB
J Cell Physiol; 2000 Apr; 183(1):18-27. PubMed ID: 10699962
[TBL] [Abstract][Full Text] [Related]
8. Reduced expression of p27/Kip1 is associated with the development of pulmonary adenocarcinoma.
Hayashi H; Ito T; Yazawa T; Ikeda M; Inayama Y; Nakatani Y; Kameda Y; Nakamura N; Kitamura H
J Pathol; 2000 Sep; 192(1):26-31. PubMed ID: 10951396
[TBL] [Abstract][Full Text] [Related]
9. Loss of the cyclin-dependent kinase inhibitor p27(Kip1) protein in human prostate cancer correlates with tumor grade.
Guo Y; Sklar GN; Borkowski A; Kyprianou N
Clin Cancer Res; 1997 Dec; 3(12 Pt 1):2269-74. PubMed ID: 9815624
[TBL] [Abstract][Full Text] [Related]
10. The prognostic impact of cyclin dependent kinase inhibitors p21WAF1, p27Kip1, and p16INK4/MTS1 in adenocarcinomas of the uterine cervix: an immunohistochemical evaluation of expression patterns in population-based material from 142 patients with international federation of gynecology and obstetrics stage I and II adenocarcinoma.
Alfsen GC; Reed W; Sandstad B; Kristensen GB; Abeler VM
Cancer; 2003 Nov; 98(9):1880-9. PubMed ID: 14584070
[TBL] [Abstract][Full Text] [Related]
11. Prognostic significance of p27/kip1 and apoptosis in patients with colorectal carcinoma.
Noguchi T; Kikuchi R; Ono K; Takeno S; Moriyama H; Uchida Y
Oncol Rep; 2003; 10(4):827-31. PubMed ID: 12792730
[TBL] [Abstract][Full Text] [Related]
12. Low expression of p27(Kip1), a cyclin-dependent kinase inhibitor, is a marker of poor prognosis in synovial sarcoma.
Kawauchi S; Goto Y; Liu XP; Furuya T; Oga A; Oda Y; Tsuneyoshi M; Ihara K; Sasaki K
Cancer; 2001 Mar; 91(5):1005-12. PubMed ID: 11251953
[TBL] [Abstract][Full Text] [Related]
13. Differential expression of p16/p21/p27 and cyclin D1/D3, and their relationships to cell proliferation, apoptosis, and tumour progression in invasive ductal carcinoma of the breast.
Wong SC; Chan JK; Lee KC; Hsiao WL
J Pathol; 2001 May; 194(1):35-42. PubMed ID: 11329139
[TBL] [Abstract][Full Text] [Related]
14. Frequent loss of expression of the cyclin-dependent kinase inhibitor p27(Kip1) in estrogen-related Endometrial adenocarcinomas.
Masciullo V; Susini T; Zamparelli A; Bovicelli A; Minimo C; Massi D; Taddei G; Maggiano N; De Iaco P; Ceccaroni M; Bovicelli L; Amunni G; Mancuso S; Scambia G; Giordano A
Clin Cancer Res; 2003 Nov; 9(14):5332-8. PubMed ID: 14614018
[TBL] [Abstract][Full Text] [Related]
15. Expression of p27(Kip1) protein in transitional cell carcinoma of the upper urinary tract.
Nakanishi K; Kawai T; Aida S; Kasamatsu H; Aurues T; Ikeda T
Mod Pathol; 2001 May; 14(5):371-6. PubMed ID: 11353044
[TBL] [Abstract][Full Text] [Related]
16. p27/Kip1 mutation found in breast cancer.
Spirin KS; Simpson JF; Takeuchi S; Kawamata N; Miller CW; Koeffler HP
Cancer Res; 1996 May; 56(10):2400-4. PubMed ID: 8625318
[TBL] [Abstract][Full Text] [Related]
17. Reduced expression of p27(Kip1) protein in relation to salivary adenoid cystic carcinoma metastasis.
Takata T; Kudo Y; Zhao M; Ogawa I; Miyauchi M; Sato S; Cheng J; Nikai H
Cancer; 1999 Sep; 86(6):928-35. PubMed ID: 10491517
[TBL] [Abstract][Full Text] [Related]
18. Decreased immunoreactivity for p27 protein in patients with early-stage breast carcinoma is correlated with HER-2/neu overexpression and with benefit from one course of perioperative chemotherapy in patients with negative lymph node status: results from International Breast Cancer Study Group Trial V.
Spataro VJ; Litman H; Viale G; Maffini F; Masullo M; Golouh R; Martinez-Tello FJ; Grigolato P; Shilkin KB; Gusterson BA; Castiglione-Gertsch M; Price K; Lindtner J; Cortés-Funes H; Simoncini E; Byrne MJ; Collins J; Gelber RD; Coates AS; Goldhirsch A;
Cancer; 2003 Apr; 97(7):1591-600. PubMed ID: 12655514
[TBL] [Abstract][Full Text] [Related]
19. Expression of p27kip1 in prostatic adenocarcinoma.
Cheville JC; Lloyd RV; Sebo TJ; Cheng L; Erickson L; Bostwick DG; Lohse CM; Wollan P
Mod Pathol; 1998 Apr; 11(4):324-8. PubMed ID: 9578081
[TBL] [Abstract][Full Text] [Related]
20. Frequent loss of expression of the cyclin-dependent kinase inhibitor p27 in epithelial ovarian cancer.
Masciullo V; Sgambato A; Pacilio C; Pucci B; Ferrandina G; Palazzo J; Carbone A; Cittadini A; Mancuso S; Scambia G; Giordano A
Cancer Res; 1999 Aug; 59(15):3790-4. PubMed ID: 10446997
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
